Phocas Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Phocas Financial's PCRX Position: Q2 2026 in Review
Phocas Financial sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 114,413 shares — an estimated $2.59M sold.
Phocas Financial first reported a position in PCRX in Q1 2022 and held it in 12 quarters. The position peaked at $7.13M in Q1 2022. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.
- Phocas Financial reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
- Phocas Financial sold 114,413 Pacira BioSciences shares in Q2 2026, an estimated $2.59M.
- Phocas Financial first reported a position in Pacira BioSciences in Q1 2022 and held it in 12 quarters.
- Phocas Financial's Pacira BioSciences position peaked at $7.13M in Q1 2022.
- 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.
Based on Phocas Financial's 13F filing for Q2 2026, filed 31 Jul 2026.